What are the possible causes of a platelet count of 74 ×10⁹/L (moderate thrombocytopenia)?

What Causes a Platelet Count of 74 ×10⁹/L?

A platelet count of 74 ×10⁹/L (moderate thrombocytopenia) most commonly results from decreased platelet production (bone marrow suppression from chemotherapy, infections, or hematologic disease), increased platelet destruction (immune-mediated like ITP, drug-induced, or infection-related), splenic sequestration (liver disease), or dilutional causes—with the specific etiology determined by your clinical context, medication history, and associated blood count abnormalities.

Diagnostic Framework

Immediate Considerations

First, exclude pseudothrombocytopenia by redrawing blood in a heparin or sodium citrate tube 1. This laboratory artifact from platelet clumping occurs in up to 0.1% of samples and must be ruled out before pursuing further workup.

Major Etiologic Categories

The causes of moderate thrombocytopenia (50-100 ×10⁹/L) fall into four mechanistic groups 2, 1, 3:

1. Decreased Platelet Production

• Chemotherapy-induced: Accounts for 38.5% of thrombocytopenia cases in tertiary centers 4
• Bone marrow infiltration: Leukemia, lymphoma, metastatic solid tumors
• Aplastic anemia or myelodysplastic syndromes
• Nutritional deficiencies: B12, folate deficiency
• Viral infections: HIV, hepatitis C, EBV

2. Increased Platelet Destruction

• Immune thrombocytopenia (ITP): Most common cause in patients with isolated thrombocytopenia without systemic illness 1
• Drug-induced thrombocytopenia: Common culprits include heparin (HIT occurs in up to 1% with unfractionated heparin), quinine, sulfonamides, anticonvulsants 2
• Infections: Sepsis, viral infections
• Autoimmune disorders: SLE, antiphospholipid syndrome

3. Splenic Sequestration

• Chronic liver disease with portal hypertension: Spleen can sequester up to 90% of platelets 1

4. Dilutional

• Massive transfusion or fluid resuscitation

Critical Diagnostic Algorithm

Step 1: Review the complete blood count

• Isolated thrombocytopenia (normal WBC, hemoglobin) → ITP or drug-induced most likely 1
• Pancytopenia → bone marrow failure, infiltration, or hypersplenism
• Anemia + thrombocytopenia → consider hemolysis, bleeding, or marrow disease

Step 2: Examine the peripheral blood smear

• Schistocytes present → thrombotic microangiopathy (TTP, HUS, DIC)—medical emergency 2
• Large platelets → peripheral destruction or ITP
• Blasts or abnormal cells → hematologic malignancy

Step 3: Obtain targeted history

• Medication review: Start/stop dates of all drugs, especially within past 2 weeks
• Infection symptoms: Fever, viral prodrome, HIV risk factors
• Bleeding history: Mucosal bleeding, petechiae, purpura (suggests platelet dysfunction or severe thrombocytopenia)
• Alcohol use: Chronic liver disease
• Pregnancy status: Gestational thrombocytopenia (7-10% of pregnancies) 2
• Previous platelet counts: Distinguish acute from chronic thrombocytopenia 1

Step 4: Additional laboratory tests based on clinical suspicion

• Liver function tests: Assess for cirrhosis/portal hypertension
• Coagulation studies (PT/INR, aPTT): If DIC or liver disease suspected
• Peripheral smear review by hematopathologist: Essential
• HIV, hepatitis C testing: If risk factors present
• Antiplatelet antibodies: Limited utility, not routinely recommended
• Bone marrow biopsy: Reserved for unclear cases, suspected marrow infiltration, or failure to respond to treatment

Clinical Context at Platelet Count of 74 ×10⁹/L

At this level, spontaneous bleeding is uncommon unless there is concurrent platelet dysfunction or coagulopathy 5. Patients typically remain asymptomatic or have only minor mucocutaneous bleeding (petechiae, mild purpura) 1.

Common Pitfalls to Avoid

1. Missing pseudothrombocytopenia: Always redraw with alternative anticoagulant if first presentation
2. Overlooking medication causes: Review ALL medications including over-the-counter and herbal supplements
3. Failing to recognize emergencies: TTP, HIT, and DIC require immediate intervention—look for schistocytes, recent heparin exposure, or signs of DIC
4. Assuming ITP without excluding other causes: ITP is a diagnosis of exclusion

When to Hospitalize

Admit patients with platelet count <20 ×10⁹/L on initial presentation for diagnostic confirmation, trend monitoring, and bleeding risk assessment 6. At 74 ×10⁹/L, outpatient management is appropriate if the patient is asymptomatic or has only minor mucocutaneous bleeding, with hematology follow-up within 24-72 hours 6.

Specific High-Risk Scenarios

• Pregnancy-associated thrombocytopenia: Requires differentiation between gestational thrombocytopenia (benign), preeclampsia/HELLP syndrome (emergency), or ITP
• Post-heparin exposure: Consider HIT if platelet drop >50% from baseline 5-10 days after heparin initiation—this causes thrombosis, not bleeding 2
• Fever + thrombocytopenia + neurologic changes: TTP until proven otherwise—do not transfuse platelets 5

The key to diagnosis is systematic evaluation starting with the peripheral smear and complete blood count pattern, followed by targeted testing based on clinical context rather than shotgun laboratory ordering 3.